Gamida Cell Ltd. IPO Research Information

Gamida Cell Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Gamida Cell Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Gamida Cell Ltd.	GMDA - NASDAQ	$13.00-$15.00	$8.00	$8.30	6.25 million	10/26/2018
Underwriter(s): BMO Capital, RBC Capital
Co-Manager(s): Needham & Co., Oppenheimer & Co.
Industry: Health Care
Filing(s): Filed 2018-09-28 Terms Added 2018-10-17

Gamida Cell Ltd. Quote & Chart - Click for current quote - GMDA

About Gamida Cell Ltd. (adapted from Gamida Cell Ltd. prospectus):
They are a clinical stage biopharmaceutical company leveraging our proprietary technology to develop cell therapies that are designed to cure cancer and rare, serious hematologic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "GMDA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.